Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.3025 -0.0125 (-3.97%) Streaming Delayed Price Updated: 2:02 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > What 11 Analyst Ratings Have To Say About Cybin September 01, 2023 Via Benzinga Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions August 31, 2023 Canadian next-generation psychedelics developer Mindset Pharma (OTCMKTS: MSSTF) has entered into a definitive agreement to acquire all outstanding shares of Otsuka America Inc. the U.S. arm of Otsuka... Via Benzinga Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M August 29, 2023 Silo Wellness (OTCQB: SILFF) has confirmed its intention to acquire all issued and outstanding securities of NUGL Inc./Kaya Group (OTC Pink: NUGL) in an arms-length transaction valued at $31.9... Via Benzinga Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More August 28, 2023 Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Via Benzinga 6 Analysts Have This to Say About Cybin August 15, 2023 Via Benzinga Analyst Expectations for Cybin's Future July 03, 2023 Via Benzinga Cybin: Q4 Earnings Insights June 27, 2023 Via Benzinga Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety August 28, 2023 Psychedelics biotech Cybin (NYSE: CYBN) company and UK-based Small Pharma (OTCQB: DMTTF) announced their definitive arrangement agreement for Cybin’s acquisition of all Small Pharma’s issued and o Via Benzinga Funding The Future Of Psychedelics: Cybin Launches Renewed ATM Equity Program Up To $35M August 24, 2023 Psychedelics biotech Cybin Inc. (NYSE: CYBN) announced it has renewed its previously established at-the-market (ATM) equity program allowing the company to gradually issue and sell up to $35 million... Via Benzinga Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library August 16, 2023 Cybin’s New US Patent Covers Proprietary Deuterated Psychedelic Analogs Via Benzinga Topics Intellectual Property Exposures Intellectual Property Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic August 14, 2023 Canadian clinical-stage psychedelics company Cybin (NYSE: CYBN) shared its unaudited financial results for the first quarter ended June 30, 2023: Via Benzinga Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published Via Benzinga Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M August 04, 2023 Psychedelics biotech Cybin Inc. (NYSE: CYBN) closed its recently announced overnight marketed public offering with an aggregate of 24,264,706 units Via Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances... Via Benzinga Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session August 01, 2023 Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list. Via Benzinga Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal August 01, 2023 Psychedelics company Cybin Inc. (NYSE: CYBN) announced an overnight marketed public offering of its units and confirmed its set pricing on an aggregate 24,264,706 Cybin units, at $0.34 each, for... Via Benzinga US Stocks Mixed; Pfizer Earnings Beat Views August 01, 2023 U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to... Via Benzinga Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket August 01, 2023 Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 01, 2023 It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning! Via InvestorPlace Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials July 24, 2023 Cybin One Steps Away From Complete Dosing Via Benzinga A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use July 21, 2023 A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance. Via Benzinga Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session July 06, 2023 Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer. Via Benzinga Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 World's Largest Psychedelics Conference Boasts 12K Attendees Via Benzinga Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor June 28, 2023 Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5... Via Benzinga Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More June 06, 2023 Major Investor Commits $30 Million To Psychedelics Funding Via Benzinga May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances June 01, 2023 Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May. Via Talk Markets Major Investor Commits $30M To Psychedelics Funding May 31, 2023 Canadian psychedelics biotech Cybin Inc. (NYSE: CYBN) entered into a common share purchase agreement with institutional investor Lincoln Park Capital Fund (LPC) for the sale of up to $30... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday June 06, 2023 On Tuesday, 69 stocks hit new 52-week lows. Via Benzinga Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More May 31, 2023 Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.